首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Evaluation of Anticancer Properties against Ehrlich Ascites Carcinoma (EAC) Cell Line, Cytotoxic and Analgesic Activity of Methanol Extract of Hibiscus moscheutos in Swiss Albino Mice
【24h】

Evaluation of Anticancer Properties against Ehrlich Ascites Carcinoma (EAC) Cell Line, Cytotoxic and Analgesic Activity of Methanol Extract of Hibiscus moscheutos in Swiss Albino Mice

机译:评估瑞士白化病小鼠抗腹水性癌细胞(EAC),芙蓉提取物的细胞毒性和止痛活性

获取原文
           

摘要

The present study has been designed to explore the analgesic, cytotoxic & in vivo anticancer activity of methanol extract of Hibiscus moscheutos against Ehrlich Ascites Carcinoma (EAC) in Swiss albino mice. Most of the natural sources of anticancer drugs are designed to evaluate the selective toxicity to rapidly dividing cells. The in vivo anticancer activity has been evaluated against EAC cells in Swiss albino mice by monitoring parameters including tumor cell growth inhibition, apoptosis assessment, tumor weight measurement, mean survival time and hematological parameters. This study indicated that dose of 400 mg/kg/day (i.p) that significantly increase life span, tumor cell breakdown, & decrease tumor weight, tumor cell growth rate compared to control group. Vincristine sulfate was used as a positive control (0.3 mg /kg). At the dose of 400 mg/kg/day(i.p) hematological parameters such as hemoglobin content, RBC, WBC, Lymphocytes, Neutrophils, Monocytes, Cholesterol, Triglyceride & Blood urea were significantly restored. In analgesic bioassay, the efficacy of Hibiscus moscheutos was 65.44% after orally administration (400 mg/kg). This outcome makes Hibiscus moscheutos as a possible potential candidate for using as anticancer & analgesic agent. In cytotoxic test, it showed significant result at 1479.10 μg/ml.
机译:本研究旨在探讨瑞士芙蓉的甲醇提取物对艾氏腹水癌(EAC)的镇痛,细胞毒性和体内抗癌活性。抗癌药的大多数天然来源旨在评估对快速分裂细胞的选择性毒性。通过监测包括肿瘤细胞生长抑制,凋亡评估,肿瘤重量测量,平均存活时间和血液学参数在内的参数,对瑞士白化病小鼠中的EAC细胞进行了体内抗癌活性评估。这项研究表明,与对照组相比,400 mg / kg / day(i.p)的剂量可显着延长寿命,肿瘤细胞分解并降低肿瘤重量,肿瘤细胞生长速率。硫酸长春新碱被用作阳性对照(0.3mg / kg)。以400 mg / kg / day(i.p)的剂量,血液学参数(例如血红蛋白含量,RBC,WBC,淋巴细胞,中性粒细胞,单核细胞,胆固醇,甘油三酸酯和血尿素)得以显着恢复。在止痛生物测定中,口服木槿(400 mg / kg)后,木槿的功效为65.44%。这一结果使得木槿成为用作抗癌和止痛剂的潜在潜在候选者。在细胞毒性试验中,其结果为1479.10μg/ ml。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号